Rasagiline (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Rasagiline drug offered from Teva Pharmaceuticals USA, Inc.. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Rasagiline |
| SUBSTANCE NAME: | RASAGILINE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2017-01-03 |
| END MARKETING DATE: | 0000-00-00 |
Rasagiline HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rasagiline from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2017-01-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-3060_1918ac98-0600-4b06-baa1-9b4ea4a63e4c |
| PRODUCT NDC: | 0093-3060 |
| APPLICATION NUMBER: | NDA021641 |
Other RASAGILINE MESYLATE Pharmaceutical Manufacturers / Labelers:
